TW427907B - Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders - Google Patents

Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders

Info

Publication number
TW427907B
TW427907B TW085104903A TW85104903A TW427907B TW 427907 B TW427907 B TW 427907B TW 085104903 A TW085104903 A TW 085104903A TW 85104903 A TW85104903 A TW 85104903A TW 427907 B TW427907 B TW 427907B
Authority
TW
Taiwan
Prior art keywords
cells
neurorecovery
neurodegenerative disorders
inducing
sertoli
Prior art date
Application number
TW085104903A
Other languages
Chinese (zh)
Inventor
Paul R Sanberg
Don F Cameron
Cesario V Borlongan
Original Assignee
Univ South Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/402,389 external-priority patent/US5702700A/en
Application filed by Univ South Florida filed Critical Univ South Florida
Application granted granted Critical
Publication of TW427907B publication Critical patent/TW427907B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A pharmaceutical composition for generating in situ trophic factors comprising Sertoli cells which are transplanted into a tissue in need of trophic factors of a mammal, said Sertoli cells creating trophic factors in situ, for treating a neurological disorder including a neural degeneration disorder.
TW085104903A 1995-03-13 1996-04-24 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders TW427907B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/402,389 US5702700A (en) 1995-03-13 1995-03-13 Sertoli cells as neurorecovery inducing cells for Parkinson's disease

Publications (1)

Publication Number Publication Date
TW427907B true TW427907B (en) 2001-04-01

Family

ID=23591681

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085104903A TW427907B (en) 1995-03-13 1996-04-24 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders

Country Status (7)

Country Link
EP (1) EP1006801A4 (en)
JP (1) JP3699727B2 (en)
KR (1) KR100297899B1 (en)
AU (1) AU705932B2 (en)
CA (1) CA2215343C (en)
NZ (1) NZ304646A (en)
TW (1) TW427907B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401192L (en) * 1994-04-11 1995-10-12 Jne Ab Symmetry measuring device
SE524543C2 (en) 2002-01-17 2004-08-24 Jne Ab Measuring ruler, intended for symmetry measurements on vehicles
CN100572535C (en) 2002-10-22 2009-12-23 卫材R&D管理有限公司 Specific expressed gene in the product dopaminergic neuron precursor cell after division stops
CA2574177C (en) 2004-07-22 2019-01-08 Eisai Co., Ltd. Lrp4/corin dopaminergic neuron progenitor cell markers
US8198081B2 (en) 2006-04-11 2012-06-12 Eisai R&D Management Co., Ltd. Dopaminergic neuron progenitor cell marker 187A5

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
AU665933B2 (en) * 1990-10-19 1996-01-25 New York University A method for transplanting cells into the brain and therapeutic uses therefor
US5702700A (en) * 1995-03-13 1997-12-30 University Of South Florida Sertoli cells as neurorecovery inducing cells for Parkinson's disease

Also Published As

Publication number Publication date
KR100297899B1 (en) 2001-10-25
EP1006801A1 (en) 2000-06-14
CA2215343C (en) 2002-02-19
AU5189796A (en) 1996-10-02
KR19980703028A (en) 1998-09-05
EP1006801A4 (en) 2001-05-02
NZ304646A (en) 1998-01-26
MX9707028A (en) 1998-06-28
JP3699727B2 (en) 2005-09-28
JPH11501818A (en) 1999-02-16
CA2215343A1 (en) 1996-09-19
AU705932B2 (en) 1999-06-03

Similar Documents

Publication Publication Date Title
EP1014881A4 (en) Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
AU8658298A (en) Method for preventing and treating hearing loss using a neurturin protein product
AU1505788A (en) A method and a composition for treating neurological diseases such as migraine, by influencing the nerve cells
ES2149888T3 (en) 3- (3,4-DIOXIFENIL) -PIRROLIDINAS AS INHIBITORS OF TYPE IV PHOSPHODIESTERASE FOR THE TREATMENT OF INFLAMMATORY DISEASES.
EP0923293A4 (en) Treatment of diarrhea
IL125590A0 (en) Peptide immunogens
ATE492279T1 (en) BUPROPINE METABOLITES FOR THE TREATMENT OF DEMENTIA AND OTHER CEREBROVACCULAR DISEASES
IL146482A (en) Tek antagonists
MY115977A (en) Synthetic excitatory amino acids
WO1997005252A3 (en) Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases
PL335254A1 (en) Methods of treating vomiting and central nervous system disorders by means ogf(+) norcisapride
SG63615A1 (en) Dna encoding a human calcium channel alpha-ie subunit
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
TR200001471T2 (en) Use of aminomethyl-chroma substitute for the prevention of nerve cell degeneration and regeneration of nerve cells.
WO1998029108A3 (en) Compositions and methods for restoring a normal pattern of imprinting to cells
TW427907B (en) Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
PL325646A1 (en) Transplantation of nerve cells using pluripotential nuroepithelial cells
HK1042038A1 (en) Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
WO2000012045A3 (en) Method for treating neurodegenerative disorders
HK1032752A1 (en) Compositions and methods for extending the action of clostridial neurotoxin
MXPA02000680A (en) Vgf polypeptides and methods of treating vgf-related disorders.
EP0782630A4 (en) Polycystic kidney disease gene
HK1008882A1 (en) Neurotrophic and antiproliferative compounds
ES2186153T3 (en) SULFATE 5-ALFA-PREGNAN-3-BETA-OL-20-ONA FOR THE TREATMENT OF TUMORS AND CNS DISORDERS.
ES2196194T3 (en) IGF-I AND -II INTENDED FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM.

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent